US pharma major Merck (NYSE: MRK) has reported a Phase III success for Welireg (belzutifan) plus Keytruda (pembrolizumab) as ...
French biotech OSE Immunotherapeutics (Euronext Paris: OSE) is accelerating a strategic reset, pausing development of OSE-230 ...
Danish vaccine maker Bavarian Nordic announced today, that the board of directors has entered into an agreement with CEO, ...
United Therapeutics has announced that its long-term pivotal Phase III ADVANCE OUTCOMES study met its primary endpoint, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results